Bota Biosciences
↗Hangzhou, China (International HQ in Lafayette, CA, USA)
Bota Biosciences is a global industrial biotechnology company that leverages an AI-powered biomanufacturing platform to design, build, and scale up production-ready strains and enzymes. The company's core technology, the Bota Center, integrates computational design with high-throughput experimental automation to optimize metabolic pathways, allowing for the sustainable production of high-value molecules.
Bota Bio focuses on transforming traditional chemical manufacturing into bio-based processes across the consumer goods, food, nutrition, and pharmaceutical sectors. By combining machine learning with advanced fermentation technologies, the company accelerates the development of bio-based products from lab to commercial scale, addressing significant sustainability and efficiency challenges in the global supply chain.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Synthetic Biology / Biomanufacturing
SIZE & FINANCIALS
Employees:201-500
Revenue:$10M-$50M (estimated)
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$145M
Investors:Matrix Partners China, IDG Capital, Source Code Capital, Sherpa Healthcare Partners, Bilibili, Courtyard Ventures
STOCK
Exchange:SSE STAR Market
Ticker:688062
Market Cap:$2.2B
PIPELINE
Stage:Commercial
Lead Drug Stage:Scaling/Manufacturing
Modalities:Synthetic Biology, Enzymes, Bio-based Intermediates, Peptides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Bota Bio US Inc.
Key Partnerships:Bilibili (Strategic partnership for consumer bio-products), Global pharmaceutical companies for intermediate manufacturing
COMPETITION
Position:Emerging
Competitors:Ginkgo Bioworks, Amyris, Zymergen (Acquired by Ginkgo), Bota Bio's regional competitor: Bluepha
LEADERSHIP
Key Executives:
Chiming Sun - CEO
Scientific Founders:Chiming Sun, Cheryl Cui (Managing Director at Nest.Bio)
Board Members:Chiming Sun, Investors from Matrix and IDG
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bota Biosciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.